These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 7439991)
1. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice. Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991 [TBL] [Abstract][Full Text] [Related]
2. Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice. Krahenbuhl JL; Sharma SD; Ferraresi RW; Remington JS Infect Immun; 1981 Feb; 31(2):716-22. PubMed ID: 7216470 [TBL] [Abstract][Full Text] [Related]
3. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine. Heymer B; Finger H; Wirsing CH Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536 [TBL] [Abstract][Full Text] [Related]
4. Failure of synthetic muramyl dipeptide to increase antibacterial resistance. Finger H; Wirsing von König CH Infect Immun; 1980 Feb; 27(2):288-91. PubMed ID: 6155329 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice. Fraser-Smith EB; Matthews TR Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666 [TBL] [Abstract][Full Text] [Related]
6. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections. Osada Y; Mitsuyama M; Une T; Matsumoto K; Otani T; Satoh M; Ogawa H; Nomoto K Infect Immun; 1982 Jul; 37(1):292-300. PubMed ID: 6809630 [TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP. Leclerc C; Juy D; Bourgeois E; Chedid L Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275 [No Abstract] [Full Text] [Related]
8. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice. Masihi KN; Brehmer W; Lange W; Ribi E; Schwartzman S J Biol Response Mod; 1984 Dec; 3(6):663-71. PubMed ID: 6439830 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of nonspecific host resistance to infection induced by muramyldipeptides. Matsumoto K; Ogawa H; Nagase O; Kusama T; Azuma I Microbiol Immunol; 1981; 25(10):1047-58. PubMed ID: 7031443 [TBL] [Abstract][Full Text] [Related]
10. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs. Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554 [TBL] [Abstract][Full Text] [Related]
11. Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptides. Bahr GM; Chedid LA; Behbehani K Cell Immunol; 1987 Jul; 107(2):443-54. PubMed ID: 3496165 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1. Iribe H; Koga T Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683 [TBL] [Abstract][Full Text] [Related]
14. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens. Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961 [TBL] [Abstract][Full Text] [Related]
15. Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro. Bakker-Woudenberg IA; Lokerse AF; Vink-van den Berg JC; Roerdink FH Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):603-9. PubMed ID: 2506020 [TBL] [Abstract][Full Text] [Related]
17. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide. Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336 [TBL] [Abstract][Full Text] [Related]
18. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives. Löwy I; Leclerc C; Chedid L Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092 [TBL] [Abstract][Full Text] [Related]
19. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide. Sone S; Tsubura E J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine. Matsumoto K; Otani T; Une T; Osada Y; Ogawa H; Azuma I Infect Immun; 1983 Mar; 39(3):1029-40. PubMed ID: 6341226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]